{{Rsnum
|rsid=16861205
|Gene=ADIPOQ
|Chromosome=3
|position=186843845
|Orientation=plus
|GMAF=0.1529
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ADIPOQ
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 15.0 | 84.1
| HCB | 3.6 | 28.5 | 67.9
| JPT | 5.3 | 38.9 | 55.8
| YRI | 5.4 | 37.4 | 57.1
| ASW | 10.5 | 33.3 | 56.1
| CHB | 3.6 | 28.5 | 67.9
| CHD | 2.8 | 26.6 | 70.6
| GIH | 0.0 | 7.9 | 92.1
| LWK | 7.3 | 33.6 | 59.1
| MEX | 5.2 | 27.6 | 67.2
| MKK | 0.6 | 22.4 | 76.9
| TSI | 1.0 | 10.8 | 88.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=21960694
|Title=Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer
|OA=1
}}

{{PMID Auto
|PMID=21155030
|Title=Association of the adiponectin gene variations with risk of ischemic stroke in a Korean population.
|OA=1
}}

{{PMID Auto
|PMID=21219602
|Title=Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study.
|OA=1
}}

{{PMID Auto
|PMID=22023374
|Title=Application of back propagation artificial neural network on genetic variants in adiponectin ADIPOQ, peroxisome proliferator-activated receptor-gamma, and retinoid X receptor-alpha genes and type 2 diabetes risk in a Chinese Han population.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}